ALLOGENE THERAPEUTICS INC (ALLO)       10.67  -0.13 (-1.2%)

10.67  -0.13 (-1.2%)

US0197701065 - Common Stock - After market: 10.78 +0.11 (+1.03%)

Buy % Consensus

82
Analysts have set a mean price target of 27.86. This target is 161.09% above the current price.
ALLO was analyzed by 25 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ALLO.
In the previous month the buy percentage consensus was at a similar level.
ALLO was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 10.6713.1326.5227.8657.75 - 23.06% 148.55% 161.09% 441.24%

Up and Down Grades

Date Firm Action Rating
2022-09-22 B. Riley Securities Maintains Buy
2022-08-10 Oppenheimer Maintains Outperform
2022-08-10 RBC Capital Maintains Outperform
2022-08-10 Raymond James Downgrade Outperform -> Market Perform
2022-07-15 Goldman Sachs Upgrade Neutral -> Buy
2022-06-03 Baird Initiate Neutral
2022-05-24 Goldman Sachs Maintains Neutral
2022-05-05 Raymond James Maintains Outperform
2022-03-07 Goldman Sachs Maintains Neutral
2021-12-14 RBC Capital Maintains Outperform
2021-10-12 JMP Securities Maintains Market Outperform
2021-10-08 RBC Capital Maintains Outperform
2021-10-08 Stifel Downgrade Buy -> Hold
2021-10-08 Goldman Sachs Downgrade Buy -> Neutral
2021-09-24 Raymond James Upgrade Market Perform -> Outperform
2021-09-23 Raymond James Upgrade Market Perform -> Outperform
2021-05-20 Truist Securities Upgrade Hold -> Buy
2021-05-14 B. Riley Securities Initiate Buy
2021-03-01 HC Wainwright & Co. Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA